Related references
Note: Only part of the references are listed.Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus
Ellen Ginzler et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
THE ROLE OF LOCAL BISPHOSPHONATES IN THE PRESERVATION OF THE BMD IN THE ZONE OF SURGICAL BONE DEFECT (ANIMAL STUDIES)
A. Torgashin et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Novel paradigms in systemic lupus erythematosus
Thomas Doerner et al.
LANCET (2019)
Disease course patterns in systemic lupus erythematosus
K. Tselios et al.
LUPUS (2019)
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Fengchun Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus A systematic review and meta-analysis
Pravesh Kumar Bundhun et al.
MEDICINE (2017)
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
William Stohl et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort
Noerni Gyori et al.
LUPUS SCIENCE & MEDICINE (2017)
Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study
J. C. O. A. Ferreira et al.
LUPUS (2016)
Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
Rina Mina et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Update on differences between childhood-onset and adult-onset systemic lupus erythematosus
Rina Mina et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Systemic Lupus Erythematosus in Children and Adolescents
Deborah M. Levy et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2012)
Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients
Ryan Webb et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis
B. Livingston et al.
LUPUS (2011)
Childhood-Onset Disease as a Predictor of Mortality in an Adult Cohort of Patients With Systemic Lupus Erythematosus
Aimee O. Hersh et al.
ARTHRITIS CARE & RESEARCH (2010)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
Hermine I. Brunner et al.
ARTHRITIS AND RHEUMATISM (2008)
Adolescent onset of lupus results in moire aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
L. B. Tucker et al.
LUPUS (2008)
Herpes zoster in juvenile-onset systemic lupus erythematosus - Incidence, clinical characteristics and risk factors
Pamela P. W. Lee et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
The Pediatric Rheumatology International Trials Organization American-College-of-Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus:: Prospective validation of the definition of improvement
Nicolino Ruperto et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
The pediatric rheumatology international trials organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus - Prospective validation of the disease activity core set
N Ruperto et al.
ARTHRITIS AND RHEUMATISM (2005)
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
KP Baker et al.
ARTHRITIS AND RHEUMATISM (2003)
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
N Ruperto et al.
RHEUMATOLOGY (2003)
Share Paper
